Are statins harmfull

The short version: statins are not harmless. They cut heart attacks and death in people who already have heart disease, and they cause real muscle and liver harm and raise diabetes risk. Whether that trade is worth it depends on who you are.

For people with established heart disease, the benefit is real and measured in deaths. A meta-analysis of 31 randomized trials found statins lowered all-cause mortality from about 11 in 100 to about 10 in 100, and total stroke from about 3.7 in 100 to 3.1 in 100 [2]. In people with recent acute coronary syndrome, intensive dosing cut death from 4.6% to 3.5% [1]. That is a hard outcome, not a lab number.

The harms are also real. Intensive statin therapy tripled adverse liver events, from 0.4% to 1.4% [1]. Muscle symptoms are the big one: a review puts the observed rate at 10 to 15% in everyday practice, though trials report only 1.5 to 5%, likely because people who cannot tolerate statins were screened out before randomization [4]. Muscle biopsies from people on statins who had no muscle pain at all showed structural damage in 10 of 14, versus 1 of 8 controls [5]. Rhabdomyolysis, the severe muscle breakdown, is rare but real, and more common in the real world than in trials [3]. Statins also raise the risk of new diabetes, with one meta-analysis finding an odds ratio of 1.61 [6].

The evidence here is mostly industry-adjacent trials with hard endpoints, which is better than most drug evidence. What it does not show is long-term muscle and metabolic harm beyond a few years, or whether the muscle damage in asymptomatic people ever becomes clinical disease.

My call: for someone who has already had a heart attack or has established heart disease, the death benefit is real and worth weighing against the muscle and diabetes risk. For a healthy person with no heart disease, the case is much weaker, and the harms are the same. Confidence: moderate.